ALPHA TRIBE

Zydus Lifesciences LimitedUpdates, 24-09-2025: General Updates

24-09-2025 | 10:30 am

Zydus Lifesciences declared an ₹11 dividend at its AGM, showcasing strong growth and enhanced EPS. Key strategic moves include MedTech entry, innovation in biologics/vaccines, and AI integration. Management addressed USFDA observations at its Oncology plant, expecting no significant impact, and clarified strategic investments in various subsidiaries.

No comments yet. Be the first to comment!

All announcements from Zydus Lifesciences Limited